Skip to content

Novel Coronavirus Pneumonia Eight Stage Exercise in the Recovery of New Crown Pneumonia Patients

Novel Coronavirus Pneumonia Eight Stage Exercise in the Recovery of New Crown Pneumonia Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072597
Enrollment
Unknown
Registered
2023-06-19
Start date
2021-11-29
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recovery period of COVID-19

Interventions

Control group:Basic treatment
Test group:Eight stage exercises for rehabilitation and lung health

Sponsors

First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have been diagnosed as infected with COVID-19 pneumonia and diagnosed as mild and ordinary, meeting the discharge criteria in the Diagnosis and Treatment Plan for novel coronavirus Pneumonia (Trial Version 8). After discharge, patients who receive medical observation in the isolation medical observation point of COVID-19 pneumonia patients in Dalian Rehabilitation Center; 2. Limb muscle strength greater than level 4; 3. Agree and cooperate with treatment; 4. Be able to provide voluntarily signed informed consent forms.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed as COVID-19 but not discharged according to the Diagnosis and Treatment Plan for novel coronavirus Pneumonia (Trial Version 8); 2. Patients who test positive for nucleic acid after discharge; 3. Patients with unstable vital signs and poor control of underlying diseases; 4. Merge with other contraindications to exercise; 5. Refusing to sign the informed consent form for this study;

Design outcomes

Primary

MeasureTime frame
the depression anxiety stress scales(DASS-21);pittsburgh sleep quality index(PQSI);rating of perceived exertion(RPE);IgG;IgM;

Secondary

MeasureTime frame
hs-CRP;IL-6;CD3+?CD8+?CD4+ Tcell;NK cell;B lymphocytes;Blood glucose;Triglyceride;Total cholesterol;High-density lipoprotein;low-density lipoprotein;

Countries

China

Contacts

Public ContactYong Liu

Department of rehabilitation medicine, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China

fuwa52008@126.com+86 180 9887 6656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026